Article
Reata shares surge after surprise FDA nod for rare disease drug
Rating:
0.0
Views:
42
Likes:
1
Library:
1
Shares of U.S. biotech firm Reata Pharmaceuticals Inc more than doubled in premarket trading on Wednesday, a day after the Food and Drug Administration (FDA) approved its rare disease drug and ended years of uncertainty over its future.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value